DeutschNewstral
Article
The New York Times on 2023-04-19 20:05
An abortion pill maker is suing the F.D.A. in a bid to protect its drug if the courts order it off the market.
Related news
- The F.D.A. cleared Pfizer’s Covid pill, the first of its kind, for high-risk patients 12 and over.The New York Times
- The F.D.A. cleared a second Covid pill, developed by Merck, offering another treatment for high-risk adults.The New York Times
- Abortion Pill Maker Sues F.D.A. to Protect Drug if a Court Orders It Off the MarketThe New York Times
- Judge Invalidates F.D.A. Approval of the Abortion Pill MifepristoneThe New York Times
- F.D.A. Advisers Weigh Allowing Over-the-Counter Birth Control PillThe New York Times
- The F.D.A.’s Johnson & Johnson Vaccine Call Is No CatastropheThe New York Times
- Abortion Ruling Could Undermine the F.D.A.’s Drug-Approval AuthorityThe New York Times
- F.D.A. Approves First Over-the-Counter Birth Control Pill in the U.S.The New York Times
- I Worked at the F.D.A. The Abortion Pill Decision Is Dangerous.The New York Times
- Pfizer asked the F.D.A. to authorize its Covid antiviral pill for unvaccinated people.The New York Times
F.D.A. approves over-the-counter birth control pill, Arkansans worry about accessarktimes.com- F.D.A. Advisers Say Benefits of Over-the-Counter Birth Control Pill Outweigh RisksThe New York Times
- Coronavirus updates: The F.D.A.’s advisers will consider the next generation of Covid vaccines.The New York Times
- F.D.A. Advisers Meets on Merck’s Covid PillThe New York Times
- New Sex Drug for Women to Improve Low Libido Is Approved by the F.D.A.The New York Times
- Novartis C.E.O. Defends Company’s Decision to Withhold False Data From the F.D.A.The New York Times
- Congressional Investigation into Alzheimer’s Drug Aduhelm Faults the F.D.A. and BiogenThe New York Times